Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASY: Lidocaine 5% plaster for post-craniotomy pain
NCT04169854Phase 3Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of lidocaine 10% oropharyngeal spray in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Pain intensity (Visual Analogue Scale). Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04169854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169854.